Propranolol Participates in the Treatment of Infantile Hemangioma by Inhibiting HUVECs Proliferation, Migration, Invasion, and Tube Formation
Objective. Infantile hemangiomas (IHs) are the most common benign tumors in infancy. The purpose of this study was to study the effects of propranolol on the function of human umbilical vein endothelial cells (HUVECs), in order to preliminarily elucidate the mechanism of propranolol in the treatment...
Main Authors: | Weili Yuan, Xukai Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2021/6636891 |
Similar Items
-
Propranolol inhibits the proliferation, migration and tube formation of hemangioma cells through HIF-1α dependent mechanisms
by: Y.Z. Chen, et al.
Published: (2017-10-01) -
Hemangioma infantil tratado com propranolol Propranolol treatment for hemangioma of infancy
by: Flavia Kakiuti Bonini, et al.
Published: (2011-08-01) -
Propranolol in the Treatment of Infantile Hemangiomas
by: Tan X, et al.
Published: (2021-09-01) -
Treatment of infantile hemangioma with propranolol
by: Gian Maria Pacifici -
Use of propranolol in infantile hemangioma
by: Manish K Shah, et al.
Published: (2017-01-01)